Live feed
·
PRReleasevia Quantisnow
Nautilus Biotechnology Inc. logo

Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay

ByQuantisnow·Wall Street's wire, on your screen.
NAUT· Nautilus Biotechnology Inc.
Industrials

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NAUT (Nautilus Biotechnology Inc.) and more on Quantisnow.